In this study, we demonstrated rationally designed, CLDN4-targeting liposomes that are highly specific to CLDN4 in vitro and in vivo and efficiently deliver Dox by targeting exposed CLDN4 in pancreatic cancer. The gene discussed is CLDN4; the disease is pancreatic neoplasm.